NO ACCUMULATION OF A HIGH PROPHYLACTIC NADROPARIN DOSAGE IN PATIENTS WITH MODERATE RENAL INSUFFICIENCY ASSESSED BY PEAK ANTI-XA ACTIVITY

被引：0
|
作者：
Atiq, F. [1 ]
van den Bemt, P. M. L. A. [1 ]
Leebeek, F. W. G. [1 ]
van Gelder, T. [1 ]
Versmissen, J. [1 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
来源：
CLINICAL THERAPEUTICS | 2015年 / 37卷 / 08期
关键词：
D O I：
10.1016/j.clinthera.2015.05.234
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E81 / E81
页数：1
相关论文
共 41 条
  • [1] No accumulation of a prophylactic dose of nadroparin in moderate renal insufficiency
    Atiq, F.
    van den Bemt, P. M. L. A.
    Leebeek, F. W. G.
    van Gelder, T.
    Versmissen, J.
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 2015, 73 (08): : 373 - 378
  • [2] No Accumulation of Peak Anti-Xa Activity of Tinzaparin in Elderly Patients with Moderate to Severe Renal Impairment: A Substudy of IRIS Clinical Trial.
    Siguret, Virginie
    Leizorovicz, Alain
    Pautas, Eric
    Gouin-Thibault, Isabelle
    [J]. BLOOD, 2009, 114 (22) : 77 - 77
  • [3] Anti-Xa activity in obese patients after double standard dose of nadroparin for prophylaxis
    Heizmann, M
    Baerlocher, GM
    Steinmann, F
    Horber, FF
    Wuillemin, WA
    [J]. THROMBOSIS RESEARCH, 2002, 106 (4-5) : 179 - 181
  • [4] The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patients
    L. Mast
    M. Y. M. Peeters
    M. Söhne
    C. M. Hackeng
    C. A. J. Knibbe
    M. P. H. van den Broek
    [J]. European Journal of Clinical Pharmacology, 2023, 79 : 1537 - 1547
  • [5] The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patients
    Mast, L.
    Peeters, M. Y. M.
    Soehne, M.
    Hackeng, C. M.
    Knibbe, C. A. J.
    van den Broek, M. P. H.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (11) : 1537 - 1547
  • [6] Evaluation of Target Peak Anti-Xa Levels in Obese Patients Receiving Prophylactic Enoxaparin
    Marotto, Gina
    Namba, Jennifer
    Auger, William
    Tran, Vy
    [J]. CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [7] Elderly Medical Patients Treated with Prophylactic Dosages of EnoxaparinInfluence of Renal Function on Anti-Xa Activity Level
    Isabelle Mahe
    Isabelle Gouin-Thibault
    Ludovic Drouet
    Guy Simoneau
    Heidi Di Castillo
    Virginie Siguret
    Jean-François Bergmann
    Eric Pautas
    [J]. Drugs & Aging, 2007, 24 : 63 - 71
  • [8] Empirically Reduced Dosages of Tinzaparin in Patients with Moderate-to-Severe Renal Insufficiency Lead to Inadequate Anti-Xa Levels
    Olie, Renske H.
    Meertens, Nathalie E. L.
    Henskens, Yvonne M. C.
    ten Cate, Hugo
    [J]. NEPHRON, 2017, 137 (02) : 113 - 123
  • [9] Elderly medical patients treated with prophylactic dosages of enoxaparin - Influence of renal function on anti-Xa activity level
    Mahe, Isabelle
    Gouin-Thibault, Isabelle
    Drouet, Ludovic
    Simoneau, Guy
    Di Castillo, Heidi
    Siguret, Virginie
    Bergmann, Jean-Francois
    Pautas, Eric
    [J]. DRUGS & AGING, 2007, 24 (01) : 63 - 71
  • [10] The relationship between anti-Xa activity and complications in orthopaedic patients receiving prophylactic fondaparinux
    Matsumoto, T.
    Wada, H.
    Masahiro, H.
    Wakebayashi, H.
    Yoshida, K.
    Miyamoto, N.
    Ohishi, K.
    Shimokariya, Y.
    Yamada, N.
    Sudo, A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 689 - 689
12345